212 related articles for article (PubMed ID: 15861655)
1. [Class I cytokines (interleukin-2-7, interleukin-9, interleukin-11, interleukin-12, interleukin-13, interleukin-15, granulocyte-macrophage colony-stimulating factor, granulocyte-colony stimulating factor, erythropoietin)].
Yokota T
Nihon Rinsho; 2005 Apr; 63 Suppl 4():187-92. PubMed ID: 15861655
[No Abstract] [Full Text] [Related]
2. [Class II cytokine receptors and their ligands].
Takaoka A; Yanai H
Nihon Rinsho; 2005 Apr; 63 Suppl 4():193-201. PubMed ID: 15861656
[No Abstract] [Full Text] [Related]
3. Serum cytokine levels in patients with neutropenia.
Greendyke RM; Sharma K; Gifford FR
Arch Pathol Lab Med; 1994 Dec; 118(12):1193-5. PubMed ID: 7526820
[TBL] [Abstract][Full Text] [Related]
4. Use of cytokines in human immunodeficiency virus-infected patients: colony-stimulating factors, erythropoietin, and interleukin-2.
Armstrong WS; Kazanjian P
Clin Infect Dis; 2001 Mar; 32(5):766-73. PubMed ID: 11229845
[TBL] [Abstract][Full Text] [Related]
5. Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor.
Neta R; Oppenheim JJ; Douches SD
J Immunol; 1988 Jan; 140(1):108-11. PubMed ID: 2447166
[TBL] [Abstract][Full Text] [Related]
6. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on neutrophil formation and function.
Khwaja A; Linch DC
Curr Opin Hematol; 1994 May; 1(3):216-20. PubMed ID: 9371285
[TBL] [Abstract][Full Text] [Related]
7. [Hematopoiesis. Biological mass production closely regulated by cytokines].
Olsson I; Bergh G; Ehinger M; Gullberg U
Lakartidningen; 1995 Apr; 92(14):1468-70, 1475-6. PubMed ID: 7707797
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
Bruserud O; Foss B; Petersen H
Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
[TBL] [Abstract][Full Text] [Related]
9. Cytokines in tumor therapy (GM-CSF, G-CSF, and IL-3). Proceedings of the satellite symposium to the 15th UICC Congress. Hamburg, Federal Republic of Germany, August 18, 1990.
Am J Clin Oncol; 1991; 14 Suppl 1():S1-63. PubMed ID: 1710873
[No Abstract] [Full Text] [Related]
10. [Clinical application of hematopoietic growth factor (IL-3, G-CSF, GM-CSF, and EPO)].
Motoyoshi K
Nihon Rinsho; 1992 Aug; 50(8):1967-72. PubMed ID: 1279240
[TBL] [Abstract][Full Text] [Related]
11. Acute CD4+ T lymphocyte-dependent interleukin-1-driven arthritis selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factor.
Lawlor KE; Wong PK; Campbell IK; van Rooijen N; Wicks IP
Arthritis Rheum; 2005 Dec; 52(12):3749-54. PubMed ID: 16320325
[TBL] [Abstract][Full Text] [Related]
12. [A new cytokine-receptor recognition scheme revealed by the complex structure of G-CSF and its receptor].
Aritomi M; Kunishima N; Morikawa K
Tanpakushitsu Kakusan Koso; 2000 Jul; 45(10):1713-21. PubMed ID: 10897683
[No Abstract] [Full Text] [Related]
13. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
Root RK; Dale DC
J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte and granulocyte macrophage colony-stimulating factors as therapy in human and veterinary medicine.
Fernández-Varón E; Villamayor L
Vet J; 2007 Jul; 174(1):33-41. PubMed ID: 17029990
[TBL] [Abstract][Full Text] [Related]
15. [Sequential treatment with granulocyte-colony stimulating factor (GCSF) and human recombinant erythropoietin (rH-EPO) in anemia of a patient with myelodysplastic syndrome and high blood transfusion requirements)].
Borbolla-Escoboza JR; González-Avante CM; López-Hernández MA; Flores-Chapa JD; Collados-Larumbe MT
Gac Med Mex; 1997; 133(4):355-9. PubMed ID: 9410796
[TBL] [Abstract][Full Text] [Related]
16. [Cytokines in the treatment of blood diseases].
Robak T
Acta Haematol Pol; 1995; 26(2 Suppl 1):72-8. PubMed ID: 7544526
[TBL] [Abstract][Full Text] [Related]
17. Increased cytokine levels and abnormal response of myeloid progenitor cells to granulocyte colony-stimulating factor in a case of severe congenital neutropenia. In vitro effects of stem cell factor.
Shitara T; Ijima H; Yugami S; Sotomatu M; Kuroume T
Am J Pediatr Hematol Oncol; 1994 May; 16(2):167-72. PubMed ID: 7513137
[TBL] [Abstract][Full Text] [Related]
18. Clinical uses of hematopoietic growth hormones in HIV-related illnesses.
Mitsuyasu RT
AIDS Clin Rev; 1993-1994; ():189-212. PubMed ID: 7692940
[No Abstract] [Full Text] [Related]
19. Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines.
Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Symann ML
Cancer Res; 1993 Jul; 53(13):3139-44. PubMed ID: 8319222
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic growth factors in myelodysplastic syndromes.
Blinder VS; Roboz GJ
Curr Hematol Rep; 2003 Nov; 2(6):453-8. PubMed ID: 14561388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]